• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK INC CODA LP BALLOON CATHETER; DQY CATHETER, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK INC CODA LP BALLOON CATHETER; DQY CATHETER, PERCUTANEOUS Back to Search Results
Model Number N/A
Device Problem Material Rupture (1546)
Patient Problems Death (1802); Hemorrhage/Bleeding (1888)
Event Date 08/11/2015
Event Type  Death  
Manufacturer Narrative
(b)(4).Event is still under investigation at this time.
 
Event Description
As per mhra report: a male patient of large body habitus and having vascular tortuosity and calcification, underwent elective transfemoral transcatheter aortic valve implantation (tavi) on the (b)(6) 2015.Bilateral femoral arterial access was obtained uneventfully and a 16 french sheath placed in the left femoral artery to deliver the tavi device.Two percutaneous suture closure devices from another manufacturer were utilized for pre-closure of the left femoral arterial puncture site.There was a technical issue with the first delivery device; which was unsuitable for deployment, but this was subsequently exchanged for a 2nd delivery system allowing satisfactorily deployment of a 29 mm valve in the aortic position with good function and no complications.The other manufacturer's closure devices were initially deployed following sheath removal; but were unsuccessful in controlling brisk hemorrhage.Manual pressure was therefore, utilized to control the bleeding, but this was difficult due to the large body habitus.Contralateral access from the right femoral artery was used to attempt delivery of an iliac occlusion balloon to arrest bleeding and allow surgical repair.This maneuver was unsuccessful due to vascular tortuosity and calcification.An aortic balloon was inflated slowly in the distal abdominal aorta with frequent checks for control of distal bleeding.This balloon ruptured just as control of distal bleeding was achieved resulting in a tear of the lower abdominal aorta and massive intra-abdominal hemorrhage (1820334-2015-00662).Transfusion protocol was initiated and patient received a large volume of colloids and packed red cells.Arrest of bleeding was then achieved with a second aortic balloon in the thoracic descending aorta.Stent deployment at the site of abdominal aortic rupture was contemplated but felt futile in view of prolonged hypotension and an agonal cardiac rhythm.The patient expired.Although requested, no additional information has been provided at this time.
 
Manufacturer Narrative
(b)(4).Investigation/evaluation: no images or device were returned; however, during the course of investigation, a review of the complaint history, device history record, drawing, instructions for use (ifu), quality control, and trends was conducted.Balloon and fatigue design verification testing of the balloon showed the device was capable of meeting design input requirements.Maximum inflation volume is documented on label as well as ifu.The ifu also warns to adhere to balloon inflation parameters and always monitor balloon inflation under fluoroscopic control.It was determined that the most likely cause of this failure mode is due to over inflation.We will continue to monitor for similar complaints.Per the quality engineering risk assessment no further action is required.The appropriate internal personnel will be notified and will continue to monitor for similar complaints.
 
Event Description
As per (b)(6) report: a male patient of large body habitus and having vascular tortuosity and calcification, underwent elective transfemoral transcatheter aortic valve implantation (tavi) on the (b)(6) 2015.Bilateral femoral arterial access was obtained uneventfully and a 16 french sheath placed in the left femoral artery to deliver the tavi device.Two percutaneous suture closure devices from another manufacturer were utilized for pre-closure of the left femoral arterial puncture site.There was a technical issue with the first delivery device; which was unsuitable for deployment, but this was subsequently exchanged for a 2nd delivery system allowing satisfactorily deployment of a 29 mm valve in the aortic position with good function and no complications.The other manufacturer's closure devices were initially deployed following sheath removal; but were unsuccessful in controlling brisk hemorrhage.Manual pressure was therefore, utilized to control the bleeding, but this was difficult due to the large body habitus.Contralateral access from the right femoral artery was used to attempt delivery of an iliac occlusion balloon to arrest bleeding and allow surgical repair.This maneuver was unsuccessful due to vascular tortuosity and calcification.An aortic balloon was inflated slowly in the distal abdominal aorta with frequent checks for control of distal bleeding.This balloon ruptured just as control of distal bleeding was achieved resulting in a tear of the lower abdominal aorta and massive intra-abdominal hemorrhage (1820334-2015-00662).Transfusion protocol was initiated and patient received a large volume of colloids and packed red cells.Arrest of bleeding was then achieved with a second aortic balloon in the thoracic descending aorta.Stent deployment at the site of abdominal aortic rupture was contemplated but felt futile in view of prolonged hypotension and an agonal cardiac rhythm.The patient expired.Although requested, no additional information has been provided at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CODA LP BALLOON CATHETER
Type of Device
DQY CATHETER, PERCUTANEOUS
Manufacturer (Section D)
COOK INC
750 daniels way
bloomington IN 47404
Manufacturer Contact
rita harden
750 daniels way
bloomington, IN 47404
8128294891
MDR Report Key5161547
MDR Text Key28726561
Report Number1820334-2015-00662
Device Sequence Number1
Product Code DQY
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
K032869
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other
Reporter Occupation Other
Type of Report Followup
Report Date 09/24/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue NumberCODA-2-9.0-35-120-32
Other Device ID NumberN/A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date08/11/2015
Device Age2 MO
Event Location Hospital
Initial Date Manufacturer Received Not provided
Initial Date FDA Received10/20/2015
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received09/13/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/23/2015
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
-
-